Provided by Tiger Fintech (Singapore) Pte. Ltd.

Insmed

98.73
+1.851.91%
Post-market: 98.26-0.5270-0.53%19:39 EDT
Volume:5.32M
Turnover:523.51M
Market Cap:17.98B
PE:-16.77
High:99.65
Open:96.46
Low:96.01
Close:96.88
Loading ...

Insmed Inc. Announces Inducement Grants for 150 New Employees Under 2025 Compensation Plan

Reuters
·
05 Jun

Insmed Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
05 Jun

Leerink Partners Keeps Their Buy Rating on Insmed (INSM)

TIPRANKS
·
04 Jun

Mizuho updates U.S. top picks: Adds CVS Health, PayPal and Oracle

Investing.com
·
04 Jun

Chief Legal Officer Michael Alexander Smith Reports Disposal of Common Shares of Insmed Inc

Reuters
·
04 Jun

Insmed Inc. to Present at Goldman Sachs Annual Global Healthcare Conference

Reuters
·
28 May

Director Clarissa Desjardins Reports Acquisition of Insmed Inc. Common Shares

Reuters
·
23 May

Insmed Inc. Chair and CEO William Lewis Reports Disposal of Common Shares

Reuters
·
23 May

Insmed Says Brensocatib Showed Consistent Efficacy in Non-Cystic Fibrosis Bronchiectasis

MT Newswires Live
·
22 May

Insmed’s brensocatib shows efficacy and safety in fibrosis bronchiectasis trial

TIPRANKS
·
22 May

Insmed Inc. Reveals Promising Brensocatib Results Across Key Subgroups in Landmark ASPEN Study at ATS 2025 Conference

Reuters
·
22 May

Guggenheim Keeps Their Buy Rating on Insmed (INSM)

TIPRANKS
·
20 May

Chief Medical Officer Martina Flammer Reports Disposal of Insmed Inc. Common Shares

Reuters
·
20 May

Insmed Shareholders Approve Key Proposals at Annual Meeting

TIPRANKS
·
17 May

Insmed Inc. Concluded Annual Shareholders Meeting

Reuters
·
17 May

Nicole Schaeffer Orlov, Chief People Strategy Officer, Reports Disposal of Insmed Inc. Common Shares

Reuters
·
16 May

Insmed Inc.'s Chair and CEO William Lewis Reports Disposal of Common Shares

Reuters
·
16 May

Martina Flammer, Chief Medical Officer, Reports Disposal of Insmed Inc. Common Shares

Reuters
·
16 May

Sara Bonstein, CFO of Insmed Inc., Reports Disposal of Common Shares

Reuters
·
16 May

Jefferies Initiates Coverage on Insmed With Buy Rating, $105 Price Target

MT Newswires Live
·
13 May